Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 278

1.

Prevalence and Effect on Survival of Pulmonary Hypertension in Myelofibrosis.

Austin M, Quesenberry PJ, Ventetuolo CE, Liang O, Reagan JL.

Clin Lymphoma Myeloma Leuk. 2019 Sep;19(9):593-597. doi: 10.1016/j.clml.2019.05.009. Epub 2019 May 13.

PMID:
31262666
2.

Renal Regenerative Potential of Extracellular Vesicles Derived from miRNA-Engineered Mesenchymal Stromal Cells.

Tapparo M, Bruno S, Collino F, Togliatto G, Deregibus MC, Provero P, Wen S, Quesenberry PJ, Camussi G.

Int J Mol Sci. 2019 May 14;20(10). pii: E2381. doi: 10.3390/ijms20102381.

3.

Low dose 100 cGy irradiation as a potential therapy for pulmonary hypertension.

Egan PC, Liang OD, Goldberg LR, Aliotta JM, Pereira M, Borgovan T, Dooner M, Camussi G, Klinger JR, Quesenberry PJ.

J Cell Physiol. 2019 Nov;234(11):21193-21198. doi: 10.1002/jcp.28723. Epub 2019 Apr 22.

4.

Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy.

Olszewski AJ, Chorzalska AD, Kim AS, Quesenberry PJ, Lopresti ML, Fenton MA, Reagan JL, Butera JN, Sahin I, Hamel C, Robison J, Petersen M, Dubielecka PM.

Br J Haematol. 2019 Aug;186(3):e31-e35. doi: 10.1111/bjh.15861. Epub 2019 Mar 11. No abstract available.

PMID:
30859554
5.

Daily rhythms influence the ability of lung-derived extracellular vesicles to modulate bone marrow cell phenotype.

Dooner MS, Stewart C, Deng Y, Papa E, Pereira M, Del Tatto M, Johnson S, Wen S, Amaral A, Aliotta J, Quesenberry PJ, Goldberg LR.

PLoS One. 2018 Nov 26;13(11):e0207444. doi: 10.1371/journal.pone.0207444. eCollection 2018.

6.

Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling human myelofibrosis.

Chorzalska A, Morgan J, Ahsan N, Treaba DO, Olszewski AJ, Petersen M, Kingston N, Cheng Y, Lombardo K, Schorl C, Yu X, Zini R, Pacilli A, Tepper A, Coburn J, Hryniewicz-Jankowska A, Zhao TC, Oancea E, Reagan JL, Liang O, Kotula L, Quesenberry PJ, Gruppuso PA, Manfredini R, Vannucchi AM, Dubielecka PM.

Blood. 2018 Nov 8;132(19):2053-2066. doi: 10.1182/blood-2018-05-848408. Epub 2018 Sep 13.

7.

Exosomal Tat protein activates latent HIV-1 in primary, resting CD4+ T lymphocytes.

Tang X, Lu H, Dooner M, Chapman S, Quesenberry PJ, Ramratnam B.

JCI Insight. 2018 Apr 5;3(7). pii: 95676. doi: 10.1172/jci.insight.95676. eCollection 2018 Apr 5.

8.

Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease.

Ollila TA, Olszewski AJ, Butera JN, Quesenberry MI, Quesenberry PJ, Reagan JL.

Clin Lymphoma Myeloma Leuk. 2018 Mar;18(3):204-209. doi: 10.1016/j.clml.2018.01.007. Epub 2018 Jan 31.

PMID:
29433979
9.

Endothelial to haematopoietic transition contributes to pulmonary arterial hypertension.

Liang OD, So EY, Egan PC, Goldberg LR, Aliotta JM, Wu KQ, Dubielecka PM, Ventetuolo CE, Reginato AM, Quesenberry PJ, Klinger JR.

Cardiovasc Res. 2017 Nov 1;113(13):1560-1573. doi: 10.1093/cvr/cvx161.

10.

Polarization of neutrophil granules - A characteristic of inflammatory states.

Mantripragada KC, Quesenberry PJ.

Blood Cells Mol Dis. 2018 Mar;69:74. doi: 10.1016/j.bcmd.2017.09.008. Epub 2017 Sep 25. No abstract available.

PMID:
28964680
11.

Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model.

Aliotta JM, Pereira M, Wen S, Dooner MS, Del Tatto M, Papa E, Cheng Y, Goldberg L, Ventetuolo CE, Liang O, Klinger JR, Quesenberry PJ.

Stem Cells Transl Med. 2017 Jul;6(7):1595-1606. doi: 10.1002/sctm.16-0386. Epub 2017 May 5.

12.

Low microchimeric cell density in tumors suggests alternative antineoplastic mechanism.

Jolis TW, Brucker BM, Schorl C, Butera JN, Quesenberry PJ.

Med Oncol. 2017 Apr;34(4):65. doi: 10.1007/s12032-017-0921-6. Epub 2017 Mar 22.

PMID:
28332165
13.

Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.

Aliotta JM, Pereira M, Wen S, Dooner MS, Del Tatto M, Papa E, Goldberg LR, Baird GL, Ventetuolo CE, Quesenberry PJ, Klinger JR.

Cardiovasc Res. 2016 Jun 1;110(3):319-30. doi: 10.1093/cvr/cvw054. Epub 2016 Mar 14.

14.

Role of Alix in miRNA packaging during extracellular vesicle biogenesis.

Iavello A, Frech VS, Gai C, Deregibus MC, Quesenberry PJ, Camussi G.

Int J Mol Med. 2016 Apr;37(4):958-66. doi: 10.3892/ijmm.2016.2488. Epub 2016 Feb 12.

15.

Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia.

Reagan JL, Fast LD, Nevola M, Mantripragada K, Mulder A, Claas FH, Rosati K, Schumacher A, Safran H, Young CT, Quesenberry MI, Winer ES, Butera JN, Quesenberry PJ.

Blood Cancer J. 2015 Dec 4;5:e371. doi: 10.1038/bcj.2015.100. No abstract available.

16.

Lung-derived exosome uptake into and epigenetic modulation of marrow progenitor/stem and differentiated cells.

Aliotta JM, Pereira M, Sears EH, Dooner MS, Wen S, Goldberg LR, Quesenberry PJ.

J Extracell Vesicles. 2015 Sep 16;4:26166. doi: 10.3402/jev.v4.26166. eCollection 2015.

17.

Role of extracellular RNA-carrying vesicles in cell differentiation and reprogramming.

Quesenberry PJ, Aliotta J, Deregibus MC, Camussi G.

Stem Cell Res Ther. 2015 Sep 3;6:153. doi: 10.1186/s13287-015-0150-x. Review.

18.

Potential functional applications of extracellular vesicles: a report by the NIH Common Fund Extracellular RNA Communication Consortium.

Quesenberry PJ, Aliotta J, Camussi G, Abdel-Mageed AB, Wen S, Goldberg L, Zhang HG, Tetta C, Franklin J, Coffey RJ, Danielson K, Subramanya V, Ghiran I, Das S, Chen CC, Pusic KM, Pusic AD, Chatterjee D, Kraig RP, Balaj L, Dooner M.

J Extracell Vesicles. 2015 Aug 28;4:27575. doi: 10.3402/jev.v4.27575. eCollection 2015.

19.

Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cells.

Mulvey HE, Chang A, Adler J, Del Tatto M, Perez K, Quesenberry PJ, Chatterjee D.

BMC Cancer. 2015 Aug 1;15:571. doi: 10.1186/s12885-015-1568-3.

20.

Stem cell divisions and cancer.

Quesenberry PJ, Goldberg LR.

Leukemia. 2015 Oct;29(10):1959. doi: 10.1038/leu.2015.166. Epub 2015 Jul 31. No abstract available.

21.

The emergence of extracellular vesicles in urology: fertility, cancer, biomarkers and targeted pharmacotherapy.

Tompkins AJ, Chatterjee D, Maddox M, Wang J, Arciero E, Camussi G, Quesenberry PJ, Renzulli JF.

J Extracell Vesicles. 2015 Jun 30;4:23815. doi: 10.3402/jev.v4.23815. eCollection 2015.

22.

AKI Recovery Induced by Mesenchymal Stromal Cell-Derived Extracellular Vesicles Carrying MicroRNAs.

Collino F, Bruno S, Incarnato D, Dettori D, Neri F, Provero P, Pomatto M, Oliviero S, Tetta C, Quesenberry PJ, Camussi G.

J Am Soc Nephrol. 2015 Oct;26(10):2349-60. doi: 10.1681/ASN.2014070710. Epub 2015 Apr 21.

23.

Extracellular Vesicle-Mediated Reversal of Paclitaxel Resistance in Prostate Cancer.

Wang JQ, DeChalus A, Chatterjee DN, Keller ET, Mizokami A, Camussi G, Mendelsohn AR, Renzulli Ii JF, Quesenberry PJ, Chatterjee D.

Crit Rev Oncog. 2015;20(5-6):407-17. doi: 10.1615/CritRevOncog.v20.i5-6.120. Review.

24.

Adult marrow hematopoiesis: a continuum of change.

Quesenberry PJ, Goldberg L, Dooner M, Pereira M, Aliotta J.

Leuk Suppl. 2014 Dec;3(Suppl 1):S18. doi: 10.1038/leusup.2014.10. Epub 2014 Dec 17. No abstract available.

25.

Concise reviews: A stem cell apostasy: a tale of four H words.

Quesenberry PJ, Goldberg LR, Dooner MS.

Stem Cells. 2015 Jan;33(1):15-20. doi: 10.1002/stem.1829. Review.

26.

Doublet spherocytes.

Mantripragada K, Quesenberry PJ.

Blood. 2014 Jul 3;124(1):12. No abstract available.

PMID:
25121167
27.

Marrow Hematopoietic Stem Cells Revisited: They Exist in a Continuum and are Not Defined by Standard Purification Approaches; Then There are the Microvesicles.

Quesenberry PJ, Goldberg L, Aliotta J, Dooner M.

Front Oncol. 2014 Apr 4;4:56. doi: 10.3389/fonc.2014.00056. eCollection 2014. Review.

28.

Extracellular vesicles released from mesenchymal stromal cells modulate miRNA in renal tubular cells and inhibit ATP depletion injury.

Lindoso RS, Collino F, Bruno S, Araujo DS, Sant'Anna JF, Tetta C, Provero P, Quesenberry PJ, Vieyra A, Einicker-Lamas M, Camussi G.

Stem Cells Dev. 2014 Aug 1;23(15):1809-19. doi: 10.1089/scd.2013.0618. Epub 2014 May 20.

29.

Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging.

Grange C, Tapparo M, Bruno S, Chatterjee D, Quesenberry PJ, Tetta C, Camussi G.

Int J Mol Med. 2014 May;33(5):1055-63. doi: 10.3892/ijmm.2014.1663. Epub 2014 Feb 20.

30.

Cellular phenotype and extracellular vesicles: basic and clinical considerations.

Quesenberry PJ, Goldberg LR, Aliotta JM, Dooner MS, Pereira MG, Wen S, Camussi G.

Stem Cells Dev. 2014 Jul 1;23(13):1429-36. doi: 10.1089/scd.2013.0594. Epub 2014 Apr 1.

31.

Advances in cellular therapy for the treatment of leukemia.

Mantripragada K, Reagan JL, Quesenberry PJ, Fast LD.

Discov Med. 2014 Jan;17(91):15-24. Review.

32.

RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.

Cross-Knorr S, Lu S, Perez K, Guevara S, Brilliant K, Pisano C, Quesenberry PJ, Resnick MB, Chatterjee D.

BMC Cancer. 2013 Oct 8;13:463. doi: 10.1186/1471-2407-13-463.

33.

The murine long-term multi-lineage renewal marrow stem cell is a cycling cell.

Goldberg LR, Dooner MS, Johnson KW, Papa EF, Pereira MG, Del Tatto M, Adler DM, Aliotta JM, Quesenberry PJ.

Leukemia. 2014 Apr;28(4):813-22. doi: 10.1038/leu.2013.252. Epub 2013 Aug 30.

PMID:
23989430
34.

Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice.

Aliotta JM, Pereira M, Amaral A, Sorokina A, Igbinoba Z, Hasslinger A, El-Bizri R, Rounds SI, Quesenberry PJ, Klinger JR.

Cardiovasc Res. 2013 Dec 1;100(3):354-62. doi: 10.1093/cvr/cvt184. Epub 2013 Jul 18.

35.

Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling.

Yang W, Wang J, Moore DC, Liang H, Dooner M, Wu Q, Terek R, Chen Q, Ehrlich MG, Quesenberry PJ, Neel BG.

Nature. 2013 Jul 25;499(7459):491-5. doi: 10.1038/nature12396. Epub 2013 Jul 17.

36.

Cellular immunotherapy for refractory hematological malignancies.

Reagan JL, Fast LD, Safran H, Nevola M, Winer ES, Castillo JJ, Butera JN, Quesenberry MI, Young CT, Quesenberry PJ.

J Transl Med. 2013 Jun 19;11:150. doi: 10.1186/1479-5876-11-150.

37.

A new stem cell biology: the continuum and microvesicles.

Quesenberry PJ, Dooner MS, Goldberg LR, Aliotta JM, Pereira M, Amaral A, Del Tatto MM, Hixson DC, Ramratnam B.

Trans Am Clin Climatol Assoc. 2012;123:152-66; discussion 166.

38.

Perspectives on the Potential Therapeutic Uses of Vesicles.

Camussi G, Quesenberry PJ.

Exosomes Microvesicles. 2013;1(6). doi: 10.5772/57393.

39.

Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype.

Nakhla PS, Butera JN, Treaba DO, Castillo JJ, Quesenberry PJ.

Leuk Lymphoma. 2013 Aug;54(8):1647-51. doi: 10.3109/10428194.2012.753449. Epub 2013 Jan 2. Review.

PMID:
23185961
40.

Homing and long-term engraftment of long- and short-term renewal hematopoietic stem cells.

Liu L, Papa EF, Dooner MS, Machan JT, Johnson KW, Goldberg LR, Quesenberry PJ, Colvin GA.

PLoS One. 2012;7(2):e31300. doi: 10.1371/journal.pone.0031300. Epub 2012 Feb 9.

41.

Nonengraftment haploidentical cellular therapy for hematologic malignancies.

Reagan JL, Fast LD, Winer ES, Safran H, Butera JN, Quesenberry PJ.

Adv Hematol. 2012;2012:784213. doi: 10.1155/2012/784213. Epub 2012 Jan 18.

42.

Progenitor/stem cell fate determination: interactive dynamics of cell cycle and microvesicles.

Aliotta JM, Lee D, Puente N, Faradyan S, Sears EH, Amaral A, Goldberg L, Dooner MS, Pereira M, Quesenberry PJ.

Stem Cells Dev. 2012 Jul 1;21(10):1627-38. doi: 10.1089/scd.2011.0550. Epub 2012 Feb 15.

43.

Stable cell fate changes in marrow cells induced by lung-derived microvesicles.

Aliotta JM, Pereira M, Li M, Amaral A, Sorokina A, Dooner MS, Sears EH, Brilliant K, Ramratnam B, Hixson DC, Quesenberry PJ.

J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18163. eCollection 2012.

44.

Marrow cell genetic phenotype change induced by human lung cancer cells.

Del Tatto M, Ng T, Aliotta JM, Colvin GA, Dooner MS, Berz D, Dooner GJ, Papa EF, Hixson DC, Ramratnam B, Aswad BI, Sears EH, Reagan J, Quesenberry PJ.

Exp Hematol. 2011 Nov;39(11):1072-80. doi: 10.1016/j.exphem.2011.08.008. Epub 2011 Aug 22.

45.

The Evi1, microRNA-143, K-Ras axis in colon cancer.

Gao JS, Zhang Y, Tang X, Tucker LD, Tarwater PM, Quesenberry PJ, Rigoutsos I, Ramratnam B.

FEBS Lett. 2011 Feb 18;585(4):693-9. doi: 10.1016/j.febslet.2011.01.033. Epub 2011 Jan 26.

46.

Cellular phenotype switching and microvesicles.

Quesenberry PJ, Aliotta JM.

Adv Drug Deliv Rev. 2010 Sep 30;62(12):1141-8. doi: 10.1016/j.addr.2010.06.001. Epub 2010 Jun 15. Review.

47.

Stem cell plasticity revisited: the continuum marrow model and phenotypic changes mediated by microvesicles.

Quesenberry PJ, Dooner MS, Aliotta JM.

Exp Hematol. 2010 Jul;38(7):581-92. doi: 10.1016/j.exphem.2010.03.021. Epub 2010 Apr 9. Review.

48.

Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription.

Aliotta JM, Pereira M, Johnson KW, de Paz N, Dooner MS, Puente N, Ayala C, Brilliant K, Berz D, Lee D, Ramratnam B, McMillan PN, Hixson DC, Josic D, Quesenberry PJ.

Exp Hematol. 2010 Mar;38(3):233-45. doi: 10.1016/j.exphem.2010.01.002. Epub 2010 Jan 15.

49.

Intercellular transfer of proteins as identified by stable isotope labeling of amino acids in cell culture.

Li M, Aliotta JM, Asara JM, Wu Q, Dooner MS, Tucker LD, Wells A, Quesenberry PJ, Ramratnam B.

J Biol Chem. 2010 Feb 26;285(9):6285-97. doi: 10.1074/jbc.M109.057943. Epub 2009 Dec 21.

50.

Triple MEL100 therapy in multiple myeloma.

Berz D, Colvin GA, McCormack EM, Winer ES, Karwan P, Colvin L, Rathore R, Lum LG, Elfenbein GJ, Quesenberry PJ.

Transplant Proc. 2009 Nov;41(9):3863-7. doi: 10.1016/j.transproceed.2009.06.196.

PMID:
19917402

Supplemental Content

Loading ...
Support Center